Avanos Medical
(NYSE) AVNS
Avanos Medical Financials at a Glance
Market Cap
$1.17B
Revenue (TTM)
$715.90M
Net Income (TTM)
-$69.40M
EPS (TTM)
-$1.61
P/E Ratio
-15.49
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$24.93
Volume
20
Open
$24.91
Price
$24.93
Volume
20
Open
$24.91
Previous Close
$24.93
Daily Range
$24.87 - $24.94
52-Week Range
$9.30 - $25.49
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$24.93
Volume
20
Open
$24.91
Previous Close
$24.93
Daily Range
$24.87 - $24.94
52-Week Range
$9.30 - $25.49
Estimated Earnings Date
Aug 4, 2026
AVNS News
AVNS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Avanos Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
2,287
CEO
David C. Pacitti, MBA
Website
www.avanos.comHeadquarters
Alpharetta, GA 30004, US
AVNS Financials
Key Financial Metrics (TTM)
Gross Margin
48.55%
Operating Margin
-7.92%
Net Income Margin
-9.69%
Return on Equity
-8.91%
Return on Capital
-6.79%
Return on Assets
-6.61%
Earnings Yield
-6.46%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.17B
Shares Outstanding
46.85M
Volume
20
Avg. Volume
1.63M
Financials (TTM)
Gross Profit
$347.60M
Operating Income
-$56.70M
EBITDA
-$21.60M
Operating Cash Flow
$36.70M
Capital Expenditure
-$29.20M
Free Cash Flow
$7.50M
Cash & ST Invst.
$65.60M
Total Debt
$138.40M
Avanos Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$182.20M
+8.8%
Gross Profit
$88.40M
-1.6%
Gross Margin
48.52%
N/A
Market Cap
$1.17B
N/A
Market Cap/Employee
$524.43K
N/A
Employees
2,227
N/A
Net Income
$5.10M
-22.7%
EBITDA
$19.30M
-9.8%
Quarterly Fundamentals
Total Cash
$65.60M
-32.4%
Total Debt
$138.40M
-1.8%
Accounts Receivable
$103.00M
-1.7%
Inventory
$141.30M
+2.3%
Long Term Debt
$117.10M
-3.3%
Short Term Debt
$21.30M
+7.6%
Return on Assets
-6.61%
N/A
Return on Invested Capital
-6.17%
N/A
Free Cash Flow
-$16.60M
-187.4%
Operating Cash Flow
-$12.30M
-147.9%